Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Enveric Biosciences Inc (ENVB) vs Verisign, Inc. (VRSN) Price & Performance

Enveric Biosciences IncTrade
Verisign, Inc.Trade

Price performance (Past 24H)

Key statistics

Enveric Biosciences Inc vs Verisign, Inc. — how do they compare? Enveric Biosciences Inc trades at $1.45 (market cap $6.20M), while Verisign, Inc. trades at $287.62 (market cap $26.00B). The key difference: Verisign, Inc. is far larger — about 4193.5× Enveric Biosciences Inc's market cap, and Verisign, Inc. pays a 1.13% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.

ENVBVRSN
Market Cap
$6.20M$26.00B
Sector
HealthTechnology
52-Week High
$17.40$310.00
52-Week Low
$1.27$211.49
Enterprise Value
$1.30M$27.31B
Dividend Yield
1.13%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Enveric Biosciences Inc

ENVB trades at $1.55, down 0.64% with a bullish technical signal despite negative profitability. The company shows promising clinical progress with its lead candidate EB-003, supported by recent FDA guidance and positive preclinical data. While quarterly earnings consistently beat expectations, the company remains unprofitable with negative ROE and ROA. Analyst sentiment is positive with 75% buy ratings.

Investment outlook hinges on successful drug development milestones, with regulatory progress and intellectual property expansion providing catalysts. Key risks include clinical trial outcomes, cash burn from operations, and dependence on financing activities. The stock presents speculative growth potential for risk-tolerant investors focused on biotech innovation.

Verisign, Inc.

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

About Enveric Biosciences Inc

Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.

Read more on ENVB

About Verisign, Inc.

Verisign is the sole authorized registry for several generic top-level domains, including the widely utilized .com and .net top-level domains. The company operates critical Internet infrastructure to support the domain name system, including operating two of the world's 13 root servers that are used to route Internet traffic. In 2018, the firm sold off its Security Services business, signalling a renewed focus on the core registry business.

Read more on VRSN